Echo Therapeutics, Inc.
Echo Therapeutics,Inc. develops instruments for transdermal (through the skin) drug delivery and diagnostics. Its devices use gentle abrasion and ultrasound technologies to painlessly extract analytes or introduce drugs without breaking the skin. The firm's proprietary Prelude SkinPrep technology platform is being developed for use in glucose monitoring under the name Symphony. Echo is also developing a system to provide needle-free drug administration of lidocaine and other pharmaceuticals. Echo is also developing Azone, a transdermal technology used for reformulated drugs already on the market.
Contact Details
Executives
Chairman, President, and CEO
Patrick T. (Pat) Mooney
COO, CFO, Treasurer, and Secretary
Harry G. Mitchell